Interestingly, the use of the sodium glucose cotransporter 2 inhibitor, canagliflozin has resulted in an increase in Lachnospiraceae UCG-001 abundance in diabetic mice and in improved kidney outcomes in patients with CKD and type 2 diabetes.40 Here, SLC5A2 is linked to type 2 diabetes mellitus.